| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
100,893 |
90,290 |
$16.11M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
98,215 |
88,118 |
$14.82M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
41,169 |
35,063 |
$14.18M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
55,764 |
49,654 |
$9.54M |
| 59025 |
Fetal non-stress test |
14,419 |
7,403 |
$3.44M |
| G0378 |
Hospital observation service, per hour |
44,592 |
17,297 |
$2.78M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18,528 |
17,567 |
$2.64M |
| 70450 |
Computed tomography, head or brain; without contrast material |
22,190 |
20,400 |
$2.60M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,538 |
3,428 |
$2.60M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,592 |
2,543 |
$2.57M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17,149 |
14,830 |
$2.42M |
| S9485 |
Crisis intervention mental health services, per diem |
5,923 |
3,228 |
$2.41M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17,679 |
14,499 |
$2.41M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,785 |
13,155 |
$2.10M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17,657 |
13,900 |
$2.05M |
| J9271 |
Injection, pembrolizumab, 1 mg |
212 |
158 |
$2.03M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
32,540 |
32,244 |
$1.99M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12,970 |
12,613 |
$1.96M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
32,201 |
28,579 |
$1.93M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,917 |
1,880 |
$1.91M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
57,348 |
44,657 |
$1.84M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
24,797 |
22,617 |
$1.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,850 |
9,586 |
$1.59M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
11,534 |
10,394 |
$1.52M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12,656 |
7,973 |
$1.47M |
| 71046 |
Radiologic examination, chest; 2 views |
59,776 |
55,851 |
$1.34M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
11,744 |
11,403 |
$1.30M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
8,344 |
7,887 |
$1.22M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,028 |
7,255 |
$1.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,343 |
6,704 |
$1.11M |
| 93971 |
|
6,147 |
5,844 |
$1.06M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
43,284 |
41,694 |
$1.05M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
43,090 |
41,553 |
$1.05M |
| 80053 |
Comprehensive metabolic panel |
209,406 |
181,256 |
$1.02M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,064 |
3,095 |
$1.01M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
225,951 |
187,488 |
$983K |
| 76770 |
|
6,554 |
6,366 |
$968K |
| 76830 |
Ultrasound, transvaginal |
10,913 |
10,602 |
$966K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,084 |
5,735 |
$955K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
37,347 |
29,282 |
$945K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20,561 |
6,082 |
$928K |
| 76801 |
|
8,436 |
7,451 |
$914K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
646 |
632 |
$893K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,310 |
5,497 |
$856K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,010 |
3,117 |
$845K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13,971 |
10,642 |
$832K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
12,834 |
6,443 |
$820K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,323 |
4,124 |
$815K |
| 76642 |
|
8,184 |
7,949 |
$802K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12,902 |
12,442 |
$699K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
39,532 |
38,810 |
$607K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
32,662 |
32,386 |
$592K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
566 |
549 |
$571K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,983 |
11,868 |
$557K |
| 29075 |
|
2,148 |
1,625 |
$546K |
| 93975 |
|
4,649 |
4,490 |
$544K |
| 84443 |
Thyroid stimulating hormone (TSH) |
62,924 |
61,211 |
$534K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,694 |
12,394 |
$525K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
8,966 |
7,774 |
$501K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29,061 |
28,581 |
$493K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,471 |
2,316 |
$468K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
17,154 |
5,020 |
$455K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,464 |
2,453 |
$450K |
| 76536 |
|
3,978 |
3,890 |
$446K |
| 94060 |
|
4,631 |
4,424 |
$444K |
| 12001 |
|
1,899 |
1,869 |
$428K |
| J0875 |
Injection, dalbavancin, 5 mg |
114 |
65 |
$419K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
22,064 |
20,284 |
$406K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,881 |
2,835 |
$403K |
| 71250 |
|
6,442 |
6,098 |
$390K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
77,019 |
63,990 |
$388K |
| 93970 |
|
1,915 |
1,821 |
$378K |
| 77065 |
Tomosynthesis, mammo |
6,635 |
6,060 |
$373K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
12,376 |
11,437 |
$362K |
| 80050 |
General health panel |
25,861 |
25,261 |
$354K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
54,151 |
45,781 |
$348K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
64,917 |
59,494 |
$344K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
71,626 |
70,035 |
$328K |
| 85027 |
|
77,958 |
71,018 |
$312K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,861 |
2,727 |
$310K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
4,122 |
3,986 |
$306K |
| 84484 |
|
48,398 |
36,979 |
$296K |
| 80061 |
Lipid panel |
87,704 |
85,882 |
$294K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13,874 |
13,585 |
$290K |
| 86481 |
|
4,994 |
4,903 |
$286K |
| 97803 |
|
3,882 |
3,628 |
$279K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,791 |
4,035 |
$278K |
| 96415 |
|
1,739 |
1,164 |
$278K |
| 77066 |
Tomosynthesis, mammo |
4,595 |
4,448 |
$272K |
| 12011 |
|
948 |
941 |
$266K |
| ATP14 |
|
38,036 |
32,938 |
$262K |
| 87634 |
|
4,320 |
4,198 |
$254K |
| 99215 |
Prolong outpt/office vis |
1,559 |
1,320 |
$249K |
| 19083 |
|
185 |
183 |
$243K |
| 77080 |
|
4,954 |
4,876 |
$242K |
| 73630 |
|
9,523 |
8,357 |
$232K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,387 |
8,129 |
$229K |
| 82728 |
|
28,209 |
27,276 |
$227K |
| 73562 |
|
9,238 |
7,951 |
$226K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
65,068 |
55,912 |
$224K |
| 72100 |
|
7,762 |
7,499 |
$219K |
| 86803 |
|
22,803 |
22,383 |
$214K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
17,301 |
15,982 |
$211K |
| 93017 |
|
2,207 |
2,104 |
$209K |
| 70496 |
|
1,340 |
1,264 |
$206K |
| 84702 |
|
17,349 |
13,983 |
$205K |
| 47562 |
|
64 |
62 |
$204K |
| 43235 |
|
238 |
236 |
$199K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,260 |
1,311 |
$198K |
| 81025 |
|
36,268 |
33,163 |
$197K |
| 73610 |
|
8,254 |
7,575 |
$193K |
| 83690 |
|
40,584 |
36,334 |
$182K |
| 0002A |
|
6,139 |
5,740 |
$182K |
| 74246 |
|
977 |
972 |
$174K |
| 94727 |
|
3,827 |
3,644 |
$174K |
| 0001A |
|
6,351 |
5,930 |
$173K |
| 29065 |
|
622 |
487 |
$170K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,222 |
10,943 |
$165K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34,222 |
25,051 |
$160K |
| 81001 |
|
82,280 |
75,320 |
$159K |
| 82607 |
|
20,471 |
20,042 |
$155K |
| 83880 |
|
11,160 |
10,100 |
$154K |
| 76870 |
|
1,249 |
1,223 |
$152K |
| 87070 |
|
24,201 |
22,941 |
$151K |
| 73030 |
|
7,058 |
6,337 |
$149K |
| 77062 |
|
2,151 |
2,081 |
$147K |
| 10060 |
|
765 |
744 |
$145K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
543 |
430 |
$144K |
| 86003 |
|
2,150 |
1,896 |
$140K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,318 |
4,066 |
$139K |
| 96367 |
|
3,114 |
2,426 |
$136K |
| 87522 |
Neg quan hep c or qual rna |
4,568 |
4,461 |
$136K |
| 83550 |
|
25,984 |
25,234 |
$133K |
| 97602 |
|
739 |
515 |
$133K |
| 94664 |
|
2,451 |
2,405 |
$132K |
| 83735 |
|
38,624 |
31,687 |
$132K |
| 87340 |
|
18,970 |
18,570 |
$132K |
| 86480 |
|
3,608 |
3,469 |
$131K |
| 70486 |
|
2,426 |
2,346 |
$130K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,158 |
1,122 |
$130K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
80 |
80 |
$129K |
| 97162 |
|
3,329 |
3,056 |
$127K |
| 74018 |
|
4,240 |
3,974 |
$126K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
139 |
128 |
$118K |
| 87186 |
|
21,063 |
19,502 |
$117K |
| J0897 |
Injection, denosumab, 1 mg |
303 |
276 |
$116K |
| 90715 |
|
4,598 |
4,428 |
$111K |
| 73110 |
|
4,924 |
4,356 |
$110K |
| 93976 |
|
919 |
891 |
$110K |
| 95816 |
|
448 |
432 |
$108K |
| 88307 |
|
1,283 |
1,205 |
$108K |
| 95886 |
|
470 |
456 |
$107K |
| 87653 |
|
3,611 |
3,579 |
$106K |
| 73130 |
|
5,945 |
5,448 |
$106K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
29,589 |
23,884 |
$105K |
| 87081 |
|
17,852 |
17,311 |
$102K |
| 77061 |
|
1,404 |
1,393 |
$100K |
| 85610 |
|
52,339 |
36,090 |
$96K |
| 73502 |
|
4,711 |
4,360 |
$96K |
| 83540 |
|
24,668 |
23,976 |
$95K |
| 94729 |
|
3,824 |
3,641 |
$94K |
| 71271 |
|
2,416 |
2,361 |
$91K |
| 86850 |
|
14,255 |
13,211 |
$90K |
| 84439 |
|
16,997 |
16,420 |
$88K |
| 73140 |
|
3,156 |
2,983 |
$88K |
| 82948 |
|
31,183 |
18,965 |
$86K |
| 29125 |
|
694 |
618 |
$86K |
| 36415 |
Collection of venous blood by venipuncture |
201,845 |
164,736 |
$83K |
| 87040 |
|
11,101 |
7,368 |
$83K |
| 12002 |
|
397 |
386 |
$83K |
| 70491 |
|
453 |
445 |
$82K |
| 86140 |
|
25,679 |
22,447 |
$82K |
| 83970 |
|
6,139 |
5,886 |
$82K |
| 97802 |
|
1,003 |
994 |
$81K |
| 87902 |
|
560 |
544 |
$81K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
454 |
100 |
$81K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
646 |
625 |
$80K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
535 |
481 |
$79K |
| 86706 |
|
11,803 |
11,538 |
$76K |
| 88142 |
|
5,015 |
4,961 |
$74K |
| 82105 |
|
6,261 |
6,124 |
$73K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
38,580 |
32,451 |
$71K |
| 84703 |
|
12,708 |
11,976 |
$70K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,398 |
6,219 |
$69K |
| 87147 |
|
12,558 |
11,556 |
$68K |
| 93880 |
|
886 |
830 |
$67K |
| 86762 |
|
6,005 |
5,855 |
$67K |
| 64483 |
|
80 |
79 |
$65K |
| 88342 |
|
4,888 |
4,570 |
$65K |
| 87077 |
|
13,540 |
12,288 |
$64K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,835 |
4,106 |
$64K |
| 87517 |
|
2,102 |
2,061 |
$64K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
6,243 |
6,115 |
$62K |
| 85730 |
|
19,126 |
16,888 |
$61K |
| 71045 |
Radiologic examination, chest; single view |
13,970 |
12,632 |
$61K |
| 80076 |
|
24,596 |
21,638 |
$60K |
| 72050 |
|
880 |
871 |
$58K |
| 83655 |
|
5,266 |
5,233 |
$57K |
| 82746 |
|
7,648 |
7,460 |
$57K |
| 86618 |
|
5,318 |
5,185 |
$57K |
| 82570 |
|
24,755 |
23,574 |
$57K |
| 86592 |
|
18,669 |
18,317 |
$57K |
| 74019 |
|
1,608 |
1,563 |
$56K |
| 86038 |
|
7,394 |
7,212 |
$54K |
| 87535 |
|
2,617 |
2,554 |
$53K |
| 85379 |
|
7,965 |
7,573 |
$53K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,710 |
6,300 |
$52K |
| 73080 |
|
2,218 |
2,088 |
$52K |
| 84403 |
|
2,973 |
2,897 |
$52K |
| 97161 |
|
1,147 |
1,079 |
$51K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,176 |
486 |
$51K |
| 83021 |
|
3,408 |
3,368 |
$51K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
690 |
681 |
$48K |
| 82652 |
|
2,134 |
2,104 |
$48K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,850 |
2,800 |
$48K |
| 82784 |
|
6,801 |
5,064 |
$46K |
| 82043 |
|
20,260 |
19,689 |
$46K |
| 0012A |
|
1,941 |
1,837 |
$46K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
593 |
496 |
$46K |
| 87536 |
|
1,019 |
999 |
$45K |
| 87205 |
|
15,108 |
13,740 |
$45K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
24 |
24 |
$44K |
| 81003 |
|
30,658 |
28,757 |
$43K |
| 83605 |
|
6,923 |
5,733 |
$43K |
| 72040 |
|
1,482 |
1,441 |
$43K |
| 86900 |
|
15,165 |
13,897 |
$43K |
| 86360 |
|
1,965 |
1,938 |
$42K |
| ATP08 |
|
13,111 |
11,168 |
$42K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,283 |
9,379 |
$42K |
| 0011A |
|
2,095 |
1,918 |
$41K |
| 83001 |
|
3,167 |
3,106 |
$41K |
| 84146 |
|
2,974 |
2,915 |
$40K |
| 83516 |
|
4,573 |
3,880 |
$40K |
| 77336 |
|
709 |
311 |
$39K |
| 84112 |
|
560 |
490 |
$38K |
| 84425 |
|
2,689 |
2,652 |
$37K |
| 85652 |
|
24,252 |
21,650 |
$36K |
| 84402 |
|
2,028 |
1,984 |
$35K |
| 62323 |
|
67 |
66 |
$35K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,460 |
5,200 |
$35K |
| 87338 |
|
3,671 |
3,599 |
$35K |
| 86359 |
|
1,965 |
1,938 |
$34K |
| 77386 |
|
294 |
27 |
$34K |
| 84153 |
|
3,980 |
3,870 |
$33K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
611 |
335 |
$33K |
| 76818 |
|
530 |
366 |
$33K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
4,242 |
2,171 |
$33K |
| 86901 |
|
12,851 |
11,862 |
$33K |
| 87210 |
|
8,852 |
8,476 |
$32K |
| 76882 |
|
268 |
265 |
$31K |
| A0425 |
Ground mileage, per statute mile |
12,868 |
11,896 |
$31K |
| 86708 |
|
4,027 |
3,951 |
$31K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,440 |
782 |
$30K |
| ATP15 |
|
6,763 |
5,349 |
$30K |
| 87808 |
|
3,373 |
3,309 |
$30K |
| 72072 |
|
743 |
733 |
$29K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
15,465 |
14,226 |
$29K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
39,109 |
33,449 |
$29K |
| J2704 |
Injection, propofol, 10 mg |
24,617 |
23,238 |
$29K |
| 86694 |
|
2,309 |
1,180 |
$28K |
| 88304 |
|
5,220 |
4,962 |
$28K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,996 |
2,080 |
$28K |
| 80051 |
|
7,138 |
5,884 |
$27K |
| 86704 |
|
3,560 |
3,478 |
$27K |
| 82565 |
|
16,759 |
13,670 |
$27K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
36,338 |
30,848 |
$26K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
20,244 |
17,269 |
$26K |
| 73590 |
|
1,289 |
1,183 |
$26K |
| 84480 |
|
2,865 |
2,729 |
$26K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
2,884 |
2,865 |
$26K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
25 |
25 |
$25K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
68 |
63 |
$25K |
| 87088 |
|
4,948 |
4,472 |
$25K |
| 83002 |
|
1,570 |
1,542 |
$25K |
| 82670 |
|
1,003 |
982 |
$23K |
| 81511 |
|
598 |
591 |
$23K |
| 70498 |
|
1,180 |
1,119 |
$23K |
| 86235 |
|
502 |
437 |
$22K |
| 29405 |
|
85 |
62 |
$22K |
| ATP17 |
|
11,258 |
10,332 |
$21K |
| 86376 |
|
1,799 |
1,764 |
$20K |
| 82731 |
|
325 |
302 |
$20K |
| 84270 |
|
1,136 |
1,112 |
$20K |
| 0031A |
|
678 |
630 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16,799 |
15,686 |
$20K |
| 82951 |
|
1,705 |
1,650 |
$20K |
| 84156 |
|
10,178 |
8,964 |
$20K |
| 86780 |
|
1,993 |
1,952 |
$19K |
| 86787 |
|
2,122 |
1,997 |
$19K |
| 83721 |
|
4,657 |
4,586 |
$19K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13,491 |
12,372 |
$19K |
| 80164 |
|
2,937 |
2,632 |
$18K |
| 71101 |
|
1,240 |
1,203 |
$18K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
135 |
126 |
$18K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
849 |
364 |
$18K |
| 86709 |
|
2,743 |
2,688 |
$18K |
| 73564 |
|
665 |
587 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,445 |
9,125 |
$18K |
| 86765 |
|
2,136 |
2,060 |
$18K |
| 80055 |
|
763 |
763 |
$17K |
| 19081 |
|
15 |
14 |
$17K |
| 86431 |
|
5,061 |
4,960 |
$17K |
| 86200 |
|
2,219 |
2,186 |
$17K |
| 95800 |
|
76 |
76 |
$16K |
| 86800 |
|
1,377 |
1,356 |
$16K |
| 82550 |
|
10,562 |
9,555 |
$16K |
| 80074 |
|
387 |
384 |
$16K |
| 84460 |
|
9,370 |
8,823 |
$15K |
| 87045 |
|
2,231 |
2,129 |
$15K |
| 87899 |
|
1,689 |
1,608 |
$15K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
29 |
24 |
$14K |
| J0185 |
Injection, aprepitant, 1 mg |
56 |
36 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14,398 |
10,458 |
$14K |
| 96523 |
|
486 |
336 |
$14K |
| 86735 |
|
1,638 |
1,571 |
$14K |
| 84450 |
|
7,452 |
6,930 |
$14K |
| 96417 |
|
952 |
616 |
$14K |
| 82150 |
|
3,070 |
2,937 |
$13K |
| 82803 |
|
850 |
762 |
$13K |
| 84100 |
|
13,654 |
10,357 |
$13K |
| ATP03 |
|
5,744 |
5,279 |
$13K |
| 72081 |
|
121 |
121 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,867 |
3,223 |
$13K |
| 84520 |
|
12,965 |
10,333 |
$13K |
| 76942 |
|
42 |
40 |
$12K |
| 87046 |
|
1,793 |
1,700 |
$12K |
| 87209 |
|
783 |
694 |
$12K |
| 73090 |
|
740 |
686 |
$12K |
| 84550 |
|
8,905 |
8,450 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,819 |
4,807 |
$11K |
| 73660 |
|
258 |
251 |
$11K |
| 82785 |
|
813 |
793 |
$11K |
| 82465 |
|
3,930 |
3,894 |
$11K |
| 82950 |
|
2,443 |
2,421 |
$11K |
| 83883 |
|
1,009 |
742 |
$11K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
66 |
66 |
$10K |
| 82248 |
|
7,890 |
7,078 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,084 |
6,458 |
$10K |
| 86308 |
|
2,258 |
2,220 |
$10K |
| 93798 |
|
224 |
36 |
$10K |
| 86141 |
|
1,562 |
1,510 |
$10K |
| 85007 |
|
4,516 |
3,669 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,486 |
11,811 |
$9K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
5,486 |
5,427 |
$9K |
| 71100 |
|
236 |
227 |
$9K |
| 82627 |
|
453 |
448 |
$9K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
140 |
131 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
8,758 |
3,705 |
$9K |
| 87272 |
|
1,000 |
976 |
$8K |
| 85018 |
|
5,815 |
5,234 |
$8K |
| J3490 |
Unclassified drugs |
5,691 |
4,837 |
$8K |
| 96376 |
|
7,910 |
5,429 |
$8K |
| 82247 |
|
2,357 |
1,738 |
$8K |
| J2358 |
Injection, olanzapine, long-acting, 1 mg |
230 |
167 |
$8K |
| 72110 |
|
161 |
161 |
$8K |
| 84436 |
|
2,201 |
2,161 |
$7K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
1,130 |
1,058 |
$7K |
| 80299 |
|
1,048 |
963 |
$7K |
| 88112 |
|
72 |
62 |
$7K |
| 94761 |
|
5,675 |
5,075 |
$7K |
| A4648 |
Tissue marker, implantable, any type, each |
723 |
705 |
$7K |
| 72170 |
|
953 |
874 |
$7K |
| 72020 |
|
3,927 |
3,715 |
$7K |
| 86696 |
|
390 |
384 |
$7K |
| 29105 |
|
71 |
65 |
$7K |
| 82985 |
|
996 |
969 |
$7K |
| 74178 |
|
54 |
54 |
$7K |
| 77334 |
|
51 |
38 |
$7K |
| 83615 |
|
4,573 |
3,956 |
$7K |
| 84144 |
|
361 |
304 |
$7K |
| 85014 |
|
4,649 |
4,222 |
$7K |
| 82947 |
|
4,648 |
4,488 |
$6K |
| 97163 |
|
152 |
150 |
$6K |
| 80178 |
|
1,713 |
1,553 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
4,437 |
1,384 |
$6K |
| 86617 |
|
505 |
255 |
$6K |
| 87641 |
|
345 |
333 |
$6K |
| 94618 |
|
141 |
127 |
$6K |
| 82533 |
|
461 |
425 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,787 |
8,347 |
$6K |
| 20553 |
|
25 |
25 |
$6K |
| 87177 |
|
783 |
693 |
$6K |
| 88341 |
|
709 |
636 |
$6K |
| 82077 |
|
1,383 |
1,222 |
$6K |
| 84165 |
|
1,430 |
1,344 |
$6K |
| 86160 |
|
307 |
294 |
$6K |
| 83520 |
|
542 |
516 |
$6K |
| 80159 |
|
652 |
532 |
$6K |
| J1453 |
Injection, fosaprepitant, 1 mg |
495 |
307 |
$5K |
| 92586 |
|
16 |
16 |
$5K |
| 76885 |
|
37 |
37 |
$5K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,713 |
2,301 |
$5K |
| 84145 |
|
412 |
392 |
$5K |
| 86665 |
|
200 |
157 |
$5K |
| 86361 |
|
390 |
376 |
$5K |
| 85045 |
|
1,692 |
1,577 |
$5K |
| 97116 |
|
149 |
93 |
$5K |
| ATP09 |
|
2,151 |
1,718 |
$5K |
| 29515 |
|
36 |
36 |
$5K |
| 86695 |
|
387 |
382 |
$5K |
| 82272 |
|
2,361 |
2,251 |
$5K |
| 94760 |
|
5,131 |
4,677 |
$4K |
| 87427 |
|
560 |
537 |
$4K |
| 87350 |
|
475 |
468 |
$4K |
| 87328 |
|
459 |
440 |
$4K |
| ATP02 |
|
1,618 |
1,459 |
$4K |
| 87329 |
|
459 |
440 |
$4K |
| 84132 |
|
1,868 |
1,664 |
$4K |
| 90686 |
|
205 |
195 |
$4K |
| J1572 |
Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg |
16 |
16 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
9,772 |
8,000 |
$4K |
| 72052 |
|
59 |
59 |
$4K |
| ATP11 |
|
2,182 |
1,972 |
$4K |
| ATP18 |
|
2,752 |
2,472 |
$4K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
2,684 |
1,243 |
$4K |
| 82952 |
|
1,125 |
1,122 |
$4K |
| ATP07 |
|
1,788 |
1,681 |
$4K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,640 |
1,554 |
$4K |
| 76881 |
|
33 |
28 |
$4K |
| 86334 |
|
439 |
426 |
$4K |
| 76937 |
|
241 |
202 |
$3K |
| 81002 |
|
1,607 |
1,554 |
$3K |
| 83020 |
|
342 |
335 |
$3K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
139 |
137 |
$3K |
| 93225 |
|
51 |
51 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
2,337 |
2,246 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
5,235 |
3,948 |
$3K |
| 84432 |
|
238 |
236 |
$3K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,880 |
3,741 |
$3K |
| 29130 |
|
17 |
16 |
$3K |
| 87252 |
|
116 |
110 |
$3K |
| 80069 |
|
582 |
564 |
$3K |
| 97166 |
|
37 |
37 |
$3K |
| ATP10 |
|
1,346 |
1,224 |
$2K |
| 93226 |
|
51 |
51 |
$2K |
| 86707 |
|
244 |
240 |
$2K |
| ATP04 |
|
928 |
866 |
$2K |
| 82977 |
|
1,036 |
1,011 |
$2K |
| 80081 |
|
38 |
38 |
$2K |
| 80179 |
|
248 |
239 |
$2K |
| 86147 |
|
121 |
66 |
$2K |
| 80177 |
|
334 |
311 |
$2K |
| 73552 |
|
71 |
68 |
$2K |
| ATP16 |
|
753 |
611 |
$2K |
| 82310 |
|
1,232 |
1,037 |
$2K |
| 87625 |
|
77 |
77 |
$2K |
| 86664 |
|
155 |
154 |
$2K |
| 36592 |
|
1,000 |
516 |
$2K |
| ATP13 |
|
1,017 |
840 |
$2K |
| 84481 |
|
143 |
139 |
$2K |
| 82140 |
|
290 |
240 |
$2K |
| 86682 |
|
197 |
119 |
$2K |
| 80143 |
|
341 |
318 |
$2K |
| 87493 |
|
820 |
769 |
$2K |
| 82040 |
|
862 |
730 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
143 |
141 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,084 |
1,696 |
$2K |
| 73120 |
|
26 |
24 |
$2K |
| 81050 |
|
695 |
673 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
177 |
175 |
$2K |
| 87486 |
|
69 |
67 |
$2K |
| 86255 |
|
194 |
191 |
$2K |
| 81015 |
|
1,133 |
1,096 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,708 |
1,176 |
$2K |
| 74174 |
|
13 |
13 |
$2K |
| 87253 |
|
80 |
78 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
57 |
56 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
5,074 |
5,027 |
$2K |
| 90688 |
|
113 |
99 |
$2K |
| 82010 |
|
255 |
221 |
$2K |
| 86355 |
|
63 |
62 |
$1K |
| 86357 |
|
63 |
62 |
$1K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
192 |
138 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
11,295 |
10,000 |
$1K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
19 |
12 |
$1K |
| 86005 |
|
200 |
186 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
680 |
601 |
$1K |
| 86225 |
|
126 |
126 |
$1K |
| 86364 |
|
185 |
185 |
$1K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,799 |
2,258 |
$1K |
| 76820 |
|
38 |
14 |
$1K |
| 86039 |
|
147 |
146 |
$1K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
23 |
12 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
10,702 |
10,089 |
$1K |
| 84075 |
|
464 |
446 |
$1K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
679 |
430 |
$1K |
| 87255 |
|
43 |
43 |
$1K |
| 88313 |
|
977 |
969 |
$1K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
84 |
76 |
$1K |
| 86701 |
|
159 |
152 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
3,944 |
2,744 |
$996.36 |
| 84154 |
|
154 |
153 |
$940.07 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
388 |
363 |
$901.30 |
| 77072 |
|
14 |
14 |
$873.73 |
| C1781 |
Mesh (implantable) |
14 |
14 |
$873.47 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
394 |
366 |
$848.50 |
| 94690 |
|
408 |
248 |
$827.88 |
| 73060 |
|
26 |
25 |
$814.27 |
| 82378 |
|
104 |
90 |
$796.25 |
| 72070 |
|
13 |
13 |
$772.03 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$743.04 |
| 97597 |
|
63 |
54 |
$742.41 |
| 83498 |
|
31 |
31 |
$718.62 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
44 |
43 |
$687.08 |
| 86663 |
|
56 |
55 |
$684.26 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
18 |
16 |
$674.97 |
| 96368 |
|
146 |
95 |
$667.96 |
| 87075 |
|
95 |
89 |
$660.97 |
| 87184 |
|
115 |
111 |
$656.58 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,844 |
2,132 |
$655.07 |
| 83519 |
|
50 |
49 |
$621.82 |
| 71111 |
|
26 |
26 |
$567.83 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,202 |
654 |
$511.77 |
| 88173 |
|
29 |
26 |
$484.50 |
| 99218 |
|
26 |
12 |
$458.50 |
| 83993 |
|
40 |
39 |
$431.00 |
| 73000 |
|
13 |
12 |
$427.97 |
| J3480 |
Injection, potassium chloride, per 2 meq |
806 |
560 |
$427.49 |
| 87106 |
|
44 |
42 |
$370.22 |
| 86335 |
|
28 |
28 |
$364.18 |
| 82103 |
|
33 |
33 |
$363.55 |
| 81599 |
|
162 |
159 |
$358.40 |
| 84207 |
|
13 |
13 |
$342.01 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
122 |
115 |
$330.28 |
| 93923 |
|
13 |
13 |
$329.10 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
2,319 |
1,188 |
$328.18 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
249 |
168 |
$325.61 |
| 83718 |
|
51 |
51 |
$321.37 |
| ATP06 |
|
147 |
128 |
$307.04 |
| C1769 |
Guide wire |
1,113 |
949 |
$295.50 |
| G0008 |
Administration of influenza virus vaccine |
307 |
282 |
$282.83 |
| 95806 |
|
13 |
13 |
$275.40 |
| 82164 |
|
26 |
26 |
$271.58 |
| 82390 |
|
30 |
30 |
$261.17 |
| 85004 |
|
99 |
86 |
$248.20 |
| 85613 |
|
31 |
26 |
$246.64 |
| 86705 |
|
39 |
39 |
$245.41 |
| 81596 |
|
83 |
82 |
$244.48 |
| 86256 |
|
16 |
16 |
$222.18 |
| 94762 |
|
86 |
79 |
$218.71 |
| 87660 |
|
12 |
12 |
$194.48 |
| 87510 |
|
12 |
12 |
$194.48 |
| 87480 |
|
12 |
12 |
$194.48 |
| 85049 |
|
42 |
41 |
$185.08 |
| 86060 |
|
27 |
27 |
$176.74 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
281 |
266 |
$176.49 |
| 86692 |
|
13 |
13 |
$174.30 |
| J0571 |
Buprenorphine, oral, 1 mg |
440 |
136 |
$155.81 |
| 84155 |
|
187 |
174 |
$152.52 |
| 82365 |
|
13 |
12 |
$147.94 |
| ATP12 |
|
93 |
80 |
$139.50 |
| 80197 |
|
74 |
39 |
$133.21 |
| 87270 |
|
12 |
12 |
$131.28 |
| 80175 |
|
59 |
55 |
$128.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
74 |
24 |
$126.67 |
| 84478 |
|
45 |
37 |
$119.33 |
| 88172 |
|
17 |
14 |
$118.77 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
12 |
$113.10 |
| 80185 |
|
29 |
26 |
$109.36 |
| 85048 |
|
102 |
88 |
$102.20 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
98 |
70 |
$97.15 |
| 90716 |
|
12 |
12 |
$95.19 |
| ATP05 |
|
44 |
37 |
$90.89 |
| 90734 |
|
24 |
24 |
$89.90 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
23 |
12 |
$89.56 |
| J3411 |
Injection, thiamine hcl, 100 mg |
14 |
14 |
$86.91 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
23 |
13 |
$82.39 |
| 86015 |
|
13 |
13 |
$77.97 |
| 87341 |
|
12 |
12 |
$77.02 |
| 70360 |
|
14 |
13 |
$74.43 |
| 89051 |
|
24 |
24 |
$74.26 |
| 80503 |
|
21 |
12 |
$71.29 |
| 84479 |
|
52 |
51 |
$68.85 |
| 86593 |
|
14 |
14 |
$56.28 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
15 |
15 |
$49.67 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,315 |
1,243 |
$47.50 |
| ATP19 |
|
12 |
12 |
$34.23 |
| 82270 |
|
13 |
13 |
$30.88 |
| 80156 |
|
43 |
36 |
$28.31 |
| 84300 |
|
14 |
14 |
$25.15 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
12 |
12 |
$20.66 |
| J9190 |
Injection, fluorouracil, 500 mg |
23 |
12 |
$19.78 |
| 96411 |
|
74 |
50 |
$15.90 |
| 87269 |
|
14 |
14 |
$10.94 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
109 |
88 |
$10.22 |
| J3470 |
Injection, hyaluronidase, up to 150 units |
29 |
27 |
$9.33 |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
43 |
17 |
$8.52 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
27 |
25 |
$7.23 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
34 |
26 |
$5.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
134 |
79 |
$3.16 |
| J1836 |
Injection, metronidazole, 10 mg |
19 |
13 |
$1.88 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
18 |
16 |
$1.36 |
| 91300 |
|
3,726 |
3,367 |
$0.23 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
14 |
14 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
125 |
86 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
282 |
238 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
206 |
202 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
301 |
291 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
317 |
306 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
168 |
106 |
$0.00 |
| 76376 |
|
120 |
119 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
13 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
27 |
26 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
119 |
43 |
$0.00 |
| 84080 |
|
12 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
109 |
95 |
$0.00 |
| 80320 |
|
25 |
25 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
367 |
344 |
$0.00 |
| 91301 |
|
816 |
802 |
$0.00 |
| 77001 |
|
15 |
12 |
$0.00 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
79 |
75 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
191 |
177 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
57 |
51 |
$0.00 |
| 87640 |
|
99 |
94 |
$0.00 |
| 99156 |
|
13 |
13 |
$0.00 |
| 91303 |
|
187 |
187 |
$0.00 |
| 36591 |
|
32 |
26 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
16 |
16 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
12 |
12 |
$0.00 |